{"url_path":"/sec/hcwb/8-k/2026-05-21/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1828673/0001493152-26-024850-index.html","accession_number":"0001493152-26-024850","cik":"0001828673","ticker":"HCWB","issuer_name":"HCW Biologics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1828673/0001493152-26-024850-index.html","primary_entity_key":"0001828673","primary_entity_name":"HCW Biologics Inc."},"word_count":111,"has_tables":true,"body_markdown":"**Item\n7.01 Regulation FD Disclosure.**\n\n \n\nOn\nMay 21, 2026, the Company issued a press release announcing the pricing of this Offering described above. A copy of that press release\nis furnished as Exhibit 99.1 hereto.\n\n \n\nThe\ninformation in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of\nSection 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it\nbe deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly\nset forth by specific reference in such a filing."}